Research ArticleAccepted Article
Atrial Fibrillation/Flutter Hospitalizations among U.S. Medicaid Recipients with and without Systemic Lupus Erythematosus
Sarah K. Chen, Medha Barbhaiya, Daniel H. Solomon, Hongshu Guan, Kazuki Yoshida, Candace H. Feldman, Brendan M. Everett and Karen H. Costenbader
The Journal of Rheumatology November 2019, jrheum.190502; DOI: https://doi.org/10.3899/jrheum.190502
Sarah K. Chen
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA. This work was funded by NIH R01 AR057327, K24 AR066109 (Dr. K Costenbader), NIH R56 HL134810 (Dr. B Everett) and NIH-P30-AR072577 (VERITY). Dr. SK Chen received research support from NIH T32 AR753033. Dr. Barbhaiya is supported by the Rheumatology Research Foundation Investigator Award. Dr. CH Feldman is supported by NIH K23 AR071500. She also receives research support from BMS and Pfizer for unrelated studies. Dr. B Everett’s work on this manuscript was supported by NIH R56 HL134810. He also reports grants and personal fees from Novartis, and personal fees from Amgen, NIDDK, Roche Diagnostics, U.S. FDA, and UpToDate. Dr. K Costenbader has received research support for this study from the NIH K24 AR066109 and R01 AR057327, and unrelated research support with Merck, Astra Zeneca, Glaxo Smith Kline. Sarah K. Chen, MD, corresponding author, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115. Email schen30@bwh.harvard.edu
Medha Barbhaiya
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA. This work was funded by NIH R01 AR057327, K24 AR066109 (Dr. K Costenbader), NIH R56 HL134810 (Dr. B Everett) and NIH-P30-AR072577 (VERITY). Dr. SK Chen received research support from NIH T32 AR753033. Dr. Barbhaiya is supported by the Rheumatology Research Foundation Investigator Award. Dr. CH Feldman is supported by NIH K23 AR071500. She also receives research support from BMS and Pfizer for unrelated studies. Dr. B Everett’s work on this manuscript was supported by NIH R56 HL134810. He also reports grants and personal fees from Novartis, and personal fees from Amgen, NIDDK, Roche Diagnostics, U.S. FDA, and UpToDate. Dr. K Costenbader has received research support for this study from the NIH K24 AR066109 and R01 AR057327, and unrelated research support with Merck, Astra Zeneca, Glaxo Smith Kline. Sarah K. Chen, MD, corresponding author, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115. Email schen30@bwh.harvard.edu
Daniel H. Solomon
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA. This work was funded by NIH R01 AR057327, K24 AR066109 (Dr. K Costenbader), NIH R56 HL134810 (Dr. B Everett) and NIH-P30-AR072577 (VERITY). Dr. SK Chen received research support from NIH T32 AR753033. Dr. Barbhaiya is supported by the Rheumatology Research Foundation Investigator Award. Dr. CH Feldman is supported by NIH K23 AR071500. She also receives research support from BMS and Pfizer for unrelated studies. Dr. B Everett’s work on this manuscript was supported by NIH R56 HL134810. He also reports grants and personal fees from Novartis, and personal fees from Amgen, NIDDK, Roche Diagnostics, U.S. FDA, and UpToDate. Dr. K Costenbader has received research support for this study from the NIH K24 AR066109 and R01 AR057327, and unrelated research support with Merck, Astra Zeneca, Glaxo Smith Kline. Sarah K. Chen, MD, corresponding author, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115. Email schen30@bwh.harvard.edu
Hongshu Guan
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA. This work was funded by NIH R01 AR057327, K24 AR066109 (Dr. K Costenbader), NIH R56 HL134810 (Dr. B Everett) and NIH-P30-AR072577 (VERITY). Dr. SK Chen received research support from NIH T32 AR753033. Dr. Barbhaiya is supported by the Rheumatology Research Foundation Investigator Award. Dr. CH Feldman is supported by NIH K23 AR071500. She also receives research support from BMS and Pfizer for unrelated studies. Dr. B Everett’s work on this manuscript was supported by NIH R56 HL134810. He also reports grants and personal fees from Novartis, and personal fees from Amgen, NIDDK, Roche Diagnostics, U.S. FDA, and UpToDate. Dr. K Costenbader has received research support for this study from the NIH K24 AR066109 and R01 AR057327, and unrelated research support with Merck, Astra Zeneca, Glaxo Smith Kline. Sarah K. Chen, MD, corresponding author, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115. Email schen30@bwh.harvard.edu
Kazuki Yoshida
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA. This work was funded by NIH R01 AR057327, K24 AR066109 (Dr. K Costenbader), NIH R56 HL134810 (Dr. B Everett) and NIH-P30-AR072577 (VERITY). Dr. SK Chen received research support from NIH T32 AR753033. Dr. Barbhaiya is supported by the Rheumatology Research Foundation Investigator Award. Dr. CH Feldman is supported by NIH K23 AR071500. She also receives research support from BMS and Pfizer for unrelated studies. Dr. B Everett’s work on this manuscript was supported by NIH R56 HL134810. He also reports grants and personal fees from Novartis, and personal fees from Amgen, NIDDK, Roche Diagnostics, U.S. FDA, and UpToDate. Dr. K Costenbader has received research support for this study from the NIH K24 AR066109 and R01 AR057327, and unrelated research support with Merck, Astra Zeneca, Glaxo Smith Kline. Sarah K. Chen, MD, corresponding author, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115. Email schen30@bwh.harvard.edu
Candace H. Feldman
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA. This work was funded by NIH R01 AR057327, K24 AR066109 (Dr. K Costenbader), NIH R56 HL134810 (Dr. B Everett) and NIH-P30-AR072577 (VERITY). Dr. SK Chen received research support from NIH T32 AR753033. Dr. Barbhaiya is supported by the Rheumatology Research Foundation Investigator Award. Dr. CH Feldman is supported by NIH K23 AR071500. She also receives research support from BMS and Pfizer for unrelated studies. Dr. B Everett’s work on this manuscript was supported by NIH R56 HL134810. He also reports grants and personal fees from Novartis, and personal fees from Amgen, NIDDK, Roche Diagnostics, U.S. FDA, and UpToDate. Dr. K Costenbader has received research support for this study from the NIH K24 AR066109 and R01 AR057327, and unrelated research support with Merck, Astra Zeneca, Glaxo Smith Kline. Sarah K. Chen, MD, corresponding author, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115. Email schen30@bwh.harvard.edu
Brendan M. Everett
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA. This work was funded by NIH R01 AR057327, K24 AR066109 (Dr. K Costenbader), NIH R56 HL134810 (Dr. B Everett) and NIH-P30-AR072577 (VERITY). Dr. SK Chen received research support from NIH T32 AR753033. Dr. Barbhaiya is supported by the Rheumatology Research Foundation Investigator Award. Dr. CH Feldman is supported by NIH K23 AR071500. She also receives research support from BMS and Pfizer for unrelated studies. Dr. B Everett’s work on this manuscript was supported by NIH R56 HL134810. He also reports grants and personal fees from Novartis, and personal fees from Amgen, NIDDK, Roche Diagnostics, U.S. FDA, and UpToDate. Dr. K Costenbader has received research support for this study from the NIH K24 AR066109 and R01 AR057327, and unrelated research support with Merck, Astra Zeneca, Glaxo Smith Kline. Sarah K. Chen, MD, corresponding author, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115. Email schen30@bwh.harvard.edu
Karen H. Costenbader
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA. This work was funded by NIH R01 AR057327, K24 AR066109 (Dr. K Costenbader), NIH R56 HL134810 (Dr. B Everett) and NIH-P30-AR072577 (VERITY). Dr. SK Chen received research support from NIH T32 AR753033. Dr. Barbhaiya is supported by the Rheumatology Research Foundation Investigator Award. Dr. CH Feldman is supported by NIH K23 AR071500. She also receives research support from BMS and Pfizer for unrelated studies. Dr. B Everett’s work on this manuscript was supported by NIH R56 HL134810. He also reports grants and personal fees from Novartis, and personal fees from Amgen, NIDDK, Roche Diagnostics, U.S. FDA, and UpToDate. Dr. K Costenbader has received research support for this study from the NIH K24 AR066109 and R01 AR057327, and unrelated research support with Merck, Astra Zeneca, Glaxo Smith Kline. Sarah K. Chen, MD, corresponding author, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115. Email schen30@bwh.harvard.edu
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Atrial Fibrillation/Flutter Hospitalizations among U.S. Medicaid Recipients with and without Systemic Lupus Erythematosus
Sarah K. Chen, Medha Barbhaiya, Daniel H. Solomon, Hongshu Guan, Kazuki Yoshida, Candace H. Feldman, Brendan M. Everett, Karen H. Costenbader
The Journal of Rheumatology Nov 2019, jrheum.190502; DOI: 10.3899/jrheum.190502
Accepted manuscript
Atrial Fibrillation/Flutter Hospitalizations among U.S. Medicaid Recipients with and without Systemic Lupus Erythematosus
Sarah K. Chen, Medha Barbhaiya, Daniel H. Solomon, Hongshu Guan, Kazuki Yoshida, Candace H. Feldman, Brendan M. Everett, Karen H. Costenbader
The Journal of Rheumatology Nov 2019, jrheum.190502; DOI: 10.3899/jrheum.190502